Immunosuppressive modulation after vascularized composite allotransplantation: current practice and future directions
Vascularized composite allotransplantation (VCA) has expanded the reconstructive options for patients with devastating tissue loss, yet its dependence on lifelong, non-specific systemic immunosuppression remains a defining constraint. Because current protocols are largely extrapolated from solid organ transplantation,...